FSHD 101: What every patient needs to know
Mario Saporta, MD, PhD, MBA
1
FSHD 101: What every patient needs to know Mario Saporta, MD, PhD, - - PowerPoint PPT Presentation
FSHD 101: What every patient needs to know Mario Saporta, MD, PhD, MBA 1 FSHD 101 FSHD is a muscular dystrophy Biology of FSHD Clinical presentation What to monitor Genetics and Risk estimation Management 2 FSHD is a muscular dystrophy
1
2
3
4
5
§ One of the most common muscular dystrophies (2 – 7 per 100,000) § Approximately 21,000 in the USA § Can be diagnosed at any age § High degree of variability § Asymmetry § Two clinically identical forms
§ FSHD type 1: 95% § FSHD type 2: 5%
§ Chronic shoulder and neck pain
6
7
D4Z4 contractions (1-10 repeats)
Loss of methylation of D4Z4 Chromatin opening 4q polymorphism A
8
9
§ Respiratory involvement: Present in <10% of patients
§ Pulmonary function testing and sleep studies
§ Mostly asymptomatic arrhythmia. ECG
§ Vascular changes leading to retinal detachment and vision loss. Annual ophthalmology evaluation
§ Mild and usually asymptomatic. Audiometry.
10
12
§ FSHD type 1 § Mutation in one copy is enough to cause disease § Risk for passing disease on is 50% § Risk does not depend on gender § Up to 30% of cases are new, spontaneous mutations
13
14
15